Quantum Genomics Société Anonyme
Quantum Genomics Société Anonyme, a healthtech company, develops of drugs to treat cardiovascular diseases. Quantum Genomics Société Anonyme was incorporated in 2005 and is headquartered in Paris, France.
Market Cap & Net Worth: Quantum Genomics Société Anonyme (QNNTF)
Quantum Genomics Société Anonyme (PINK:QNNTF) has a market capitalization of $6.96 Million ($6.96 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #30407 globally and #10023 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Quantum Genomics Société Anonyme's stock price $0.10 by its total outstanding shares 69618704 (69.62 Million).
Quantum Genomics Société Anonyme Market Cap History: 2021 to 2025
Quantum Genomics Société Anonyme's market capitalization history from 2021 to 2025. Data shows change from $313.28 Million to $6.96 Million (-64.73% CAGR).
Quantum Genomics Société Anonyme Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Quantum Genomics Société Anonyme's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
11957.14x
Quantum Genomics Société Anonyme's market cap is 11957.14 times its annual revenue
1728.56x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $313.28 Million | $3.14 Million | -$17.36 Million | 99.84x | N/A |
| 2022 | $236.70 Million | $2.52 Million | -$24.94 Million | 94.11x | N/A |
| 2023 | $236.70 Million | $19.80K | -$3.17 Million | 11957.14x | N/A |
Competitor Companies of QNNTF by Market Capitalization
Companies near Quantum Genomics Société Anonyme in the global market cap rankings as of March 18, 2026.
Key companies related to Quantum Genomics Société Anonyme by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Quantum Genomics Société Anonyme Historical Marketcap From 2021 to 2025
Between 2021 and today, Quantum Genomics Société Anonyme's market cap moved from $313.28 Million to $ 6.96 Million, with a yearly change of -64.73%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $6.96 Million | 0.00% |
| 2024 | $6.96 Million | -97.06% |
| 2023 | $236.70 Million | 0.00% |
| 2022 | $236.70 Million | -24.44% |
| 2021 | $313.28 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Quantum Genomics Société Anonyme was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $6.96 Million USD |
| MoneyControl | $6.96 Million USD |
| MarketWatch | $6.96 Million USD |
| marketcap.company | $6.96 Million USD |
| Reuters | $6.96 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.